Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E.
Medicina Clinica 102(16): 637-638
1994
ISSN/ISBN: 0025-7753 PMID: 8208043 Document Number: 429736
Document emailed within 1 workday
Related Documents
Kanno, M.; Edanaga, M.; Mizukami, N.; Tokinaga, Y.; Niiyama, Y.; Yamakage, M. 2015: Successful Management of Cardiopulmonary Bypass Using Heparin in a Patient with Previous History of Heparin-induced Thrombocytopenia Masui. Japanese Journal of Anesthesiology 64(4): 449-452Ríos Herranz, E.; Briz Blanco, M.; Cabrera Marín, J.R.; Fernández Rodríquez, M.N. 1991: Thrombocytopenia induced by low molecular weight heparin Medicina Clinica 96(16): 635-636
Shah, A.C.; Genoni, M.; Niederhäuser, U.; Maloigne, M.; Turina, M. 2000: R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection Schweizerische Medizinische Wochenschrift 130(23): 896-899
Yuan, S-Min. 2015: Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy Pakistan journal of pharmaceutical sciences 28(5): 1793-1796
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Metz, D.; N'Guyen, P.; Chapoutot, L.; Graciet, J.; Taupin, J.M.; Grentzinger, A.; Elaerts, J.; Bajolet, A. 1991: Massive pulmonary embolism disclosing thrombocytopenia induced by low molecular weight heparin. Therapeutic success of prostacyclin Annales de Cardiologie et d'Angeiologie 40(10): 619-621
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Recarte García-Andrade, C.; Pastor Gómez-Cornejo, L. 1998: Autoimmune thrombocytopenia from low molecular weight heparin Anales de Medicina Interna 15(6): 339-340
Suehiro, S.; Shibata, T.; Sasaki, Y.; Hattori, K.; Kumano, H.; Hosono, M.; Kinoshita, H. 1999: Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 5(4): 225-229
Izban, K.F.; Lietz, H.W.; Hoppensteadt, D.A.; Jeske, W.P.; Fareed, J.; Bakhos, M.; Walenga, J.M. 1999: Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia Seminars in Thrombosis and Hemostasis 25(Suppl 1): 51-56
Sawai, T.; Uchida, O.; Inamori, S.; Kuro, M. 2003: Successful management after cardiopulmonary bypass without administration of protamine in a patient with severe food allergy--beneficial result with the use of heparin-coated bypass circuit Masui. Japanese Journal of Anesthesiology 52(3): 280-283
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125